ISMP Canada

ISMP Canada ISMP Canada is a national non-profit, dedicated to the prevention of harm from medications.

The Institute for Safe Medication Practices Canada is an independent national not-for-profit organization committed to the advancement of medication safety in all healthcare settings. We work collaboratively with the healthcare community, regulatory agencies and policy makers, provincial, national and international patient safety organizations, the pharmaceutical industry and the public to promote

safe medication practices. ISMP Canada's mandate includes analyzing medication incidents, making recommendations for the prevention of harmful medication incidents, and facilitating quality improvement initiatives. Information about ISMP Canada's work with Canadians to prevent medication incidents is available at: www.ismp-canada.org; and also at www.SafeMedicationUse.ca, a website designed for consumers.

09/03/2026

Medication incidents such as omissions, duplications, and dosing errors can often be prevented with the right knowledge and practical tools. 💊

Looking to strengthen your skills in Best Possible Medication History (BPMH) and Medication Reconciliation (MedRec)?

🎥 Watch the video to discover three good reasons to attend and learn how this workshop can make a difference in your daily practice.

📅 Upcoming dates:
• September 19, 2026
• November 20, 2026
• March 6, 2027

🔔 Register today: ismpcanada.ca/education

👩‍⚕️ Who should attend?
Nurses, pharmacists, pharmacy technicians, EMS professionals, care coordinators, managers, and other healthcare professionals involved in medication management.

🎉 Group discount: Send 5+ people and receive 10% off
🎓 Student discount: 50% off

🚨 Attention: hospital care providers and community pharmaciesA recent report to the NIDR described an incident where a h...
09/03/2026

🚨 Attention: hospital care providers and community pharmacies

A recent report to the NIDR described an incident where a hospital discharge prescription was sent to a community pharmacy; the anticoagulant dose was changed, and the discharge prescription was then re-sent. However, without the change noted, it was assumed to be a duplicate, and discarded. The previous, incorrect dose of the anticoagulant was dispensed, which led to the patient experiencing harm and being readmitted to hospital.

Recommendations to prevent these types of errors:
Hospital care teams:
• Incorporate start, stop, and change sections/designations on discharge prescriptions and/or discharge summaries to assist with medication reconciliation in the next care setting.

Community pharmacy teams:
• Implement an independent double check of dispensed medications against discharge prescriptions.

👉 For more information, check out ISMP Canada’s latest bulletin: https://ismpcanada.ca/bulletin/hospital-readmissions-transitions-of-care/ -discharge

🚨 Attention: Community Pharmacy Teams! 👧 The NIDR continues to receive reports of errors occurring with pediatric prescr...
09/01/2026

🚨 Attention: Community Pharmacy Teams!

👧 The NIDR continues to receive reports of errors occurring with pediatric prescriptions, especially when it comes to dose calculations. There have been reports of overdose leading to patient harm due to miscalculation of the intended dose.

Strategies to avoid these types of errors:
✅ When possible, perform an independent double check to confirm the prescribed dose.
✅ If working alone, a drug information centre or a colleague at a different pharmacy can support the double check process.
✅ Consider a delayed self-check, by pausing and coming back the prescription after some time, if unable obtain an independent double check by a second individual.

For more information on pediatric medication errors occurring in community pharmacy, review this ISMP Canada safety bulletin:

👉https://ismpcanada.ca/wp-content/uploads/ISMPCSB2022-i5-Pediatric-MIA.pdf

ATELIER : Excité de présenter notre Lynn Riley !✅Inscrivez-vous dès maintenant pour les ateliers d'analyse des incid...
08/31/2026

ATELIER : Excité de présenter notre Lynn Riley !

✅Inscrivez-vous dès maintenant pour les ateliers d'analyse des incidents et d'évaluation proactive des risques en français➡️ismpcanada.ca/fr/education
🗓️3 et 4 décembre 2026

Ne manquez pas cette opportunité !

📢 Attention: ONTARIO Long-Term Care Home TeamsREGISTER TODAY: NEW Ontario Innovator Network for Pain Management!ISMP Can...
08/27/2026

📢 Attention: ONTARIO Long-Term Care Home Teams

REGISTER TODAY: NEW Ontario Innovator Network for Pain Management!

ISMP Canada is pleased to launch the Ontario Innovator Network for Pain Management to support Homes in optimizing pain management for residents.

Join the Network to receive targeted resources and coaching from experts and become part of monthly sharing and learning webinars with other Ontario Homes.

Please visit the link below for more information and to complete your registration: https://ismpcanada.ca/innovator-homes-registration/?utm_source=prodserv&utm_medium=email&utm_campaign=ps260804

✍ Registration Deadline: September 1st, 2026

Ontario Association of Residents' Councils Ontario Long Term Care Association

ISMP Canada is undertaking an independent evaluation to examine how ISMP Canada’s work has contributed to improving medi...
08/26/2026

ISMP Canada is undertaking an independent evaluation to examine how ISMP Canada’s work has contributed to improving medication safety across Canada. The findings will support organizational learning, accountability, continuous improvement, and future planning.

Over the coming weeks, you will be invited to participate in a confidential interview, an online survey, or both. Participation is voluntary, and information collected will be kept confidential and reported only in aggregate.

Your input will help strengthen ISMP Canada’s efforts to advance medication safety in Canada.

08/24/2026

📢 Workshop: Multi-Incident Analysis & Medication Safety Culture Assessment

Join us for in-depth learning and hands-on practice to strengthen your medication safety knowledge and quality improvement skills.

💬Feedback from a past participant:
"I would recommend all of the QRMs [Quality Risk Managers] in our organization take this education as it would standardize the way we do work."

🗓️ Upcoming workshop dates:
• October 29–30, 2026
• January 21–22, 2027

💊 Don't miss this opportunity to advance your expertise.

🔔 Register today: ismpcanada.ca/education

08/20/2026

🚑 Paramedicine-Focused Virtual Workshop

Strengthen your skills in Incident Analysis and Proactive Risk Assessment with ISMP Canada's interactive virtual workshop, designed for professionals in .

🗓️ Upcoming sessions:
📌 October 1–2, 2026
📌 February 25–26, 2027

Calling all front-line providers, educators, and leaders in - join this workshop to gain practical tools to identify system factors, reduce risk, and improve patient safety.

🔔 Register today: ismpcanada.ca/education

⚠️ Attention: Community Pharmacies! 💊 ISMP Canada recently received a report involving a pediatric patient whose weight...
08/18/2026

⚠️ Attention: Community Pharmacies!



💊 ISMP Canada recently received a report involving a pediatric patient whose weight, documented in pounds, was mistakenly interpreted as kilograms. This resulted in the calculation of an excessively high (more than 2 times) weight-based medication dose.

Weight-based medication dosing errors may lead to underdosing, overdosing, and can lead to potential patient harm.



To help prevent weight-based dosing incidents:

✅ Conduct independent double checks for all weight-based dosing and dose calculations

✅ Obtain a recent weight for each patient in metric units (kg) on first encounter. Have a metric weigh scale handy!

✅ Standardize weight verification in metric units (kg) at drop-off and pick-up

Learn more about weight-based medication dose errors here: https://ismpcanada.ca/bulletin/weight-based-medication-dose-errors/

08/17/2026

⚠Teva Canada Ltd. is recalling two lots of Teva-Pregabalin 150 mg capsules after routine testing identified that some capsules 💊 may be contaminated with the drug sertraline. Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure.

🚑 If you experience a serious allergic reaction (anaphylaxis), stop taking the affected product and seek immediate medical help by calling 9-1-1. Otherwise, do not stop taking your pregabalin medication without first speaking with your healthcare professional or pharmacist, as stopping suddenly may cause withdrawal symptoms. Return the product to the pharmacy where it was purchased as soon as possible for a replacement or alternative supply, and for proper disposal. If you are unsure whether your product is recalled, check with your pharmacy.

You can read more about this advisory ➡ https://recalls-rappels.canada.ca/en/alert-recall/two-lots-teva-pregabalin-150-mg-capsules-recalled-due-cross-contamination-drug

Address

4711 Yonge Street, Suite 706
Toronto, ON
M2N6K8

Telephone

+14167333131

Website

Alerts

Be the first to know and let us send you an email when ISMP Canada posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ISMP Canada:

Shortcuts

Featured

Share

Category